Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer

Am J Hematol. 2017 Jan;92(1):E10-E11. doi: 10.1002/ajh.24590. Epub 2016 Nov 18.

Yan Dai^{1

2}, Jose Sangerman³, Mehdi Nouraie⁴, Aidan D Faller³, Patricia Oneal⁵, Angela Rock⁵, Oluwakemi Owoyemi⁵, Xiaomei Niu⁵, Sergei Nekhai⁵, Dashmeet Maharaj³, Shauiying Cui⁶, Robert Taylor⁵, Martin Steinberg^{6

7}, Susan Perrine^{1

2

3

5

8}

¹ Cancer Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
² Cancer Center, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts.
³ Hemoglobinopathy Thalassemia Research Unit, Boston University School of Medicine, Boston, Massachusetts.
⁴ Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
⁵ Center for Hemoglobin Research in Minorities (CHaRM), Howard University, Washington, District of Columbia.
⁶ Hematology Oncology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
⁷ Medicine, Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
⁸ Phoenicia Biosciences, Weston, Massachusetts.

No abstract available

Publication types